Revision history of "Increase competitiveness and increase the impact of Bowil Biotech by entering new international markets through investment in launching the production of a new biomaterial for implants resulting from its own research and development" (Q120896)

Jump to navigation Jump to search

Diff selection: Mark the radio buttons of the revisions to compare and hit enter or the button at the bottom.
Legend: (cur) = difference with latest revision, (prev) = difference with preceding revision, m = minor edit.

12 March 2024

15 January 2024

12 June 2023

24 May 2023

2 March 2023

  • curprev 19:5819:58, 2 March 2023DG Regio talk contribs 67,200 bytes +545 Changed label, description and/or aliases in da, it, lv, ro, ga, sk, fi, et, bg, hr, de, es, sv, pt, el, sl, cs, hu, lt, fr, nl, mt, and other parts

27 October 2022

26 October 2022

21 October 2022

2 July 2022

  • curprev 18:4818:48, 2 July 2022DG Regio talk contribs 64,550 bytes +40,398 Changed label, description and/or aliases in da, el, hr, ro, sk, mt, pt, fi, sl, cs, lt, lv, bg, hu, ga, sv, et, nl, fr, de, it, es, and other parts: Adding translations: da, el, hr, ro, sk, mt, pt, fi, sl, cs, lt, lv, bg, hu, ga, sv, et,

18 January 2022

15 January 2022

17 December 2021

8 December 2021

2 December 2021

  • curprev 07:3007:30, 2 December 2021DG Regio talk contribs 14,924 bytes +1,997 Created claim: summary (P836): L’objectif du projet est d’accroître la compétitivité de Bowil Biotech et d’améliorer sa capacité à développer des produits grâce à l’innovation. Le projet concerne l’investissement dans des actifs corporels liés à la modernisation de la chaîne de production de l’usine de bionanocellulose de l’entreprise. Grâce à cet investissement, l’entreprise réalisera la capacité de production de biomatériaux, qui seront utilisés dans la production de dispos...
  • curprev 07:3007:30, 2 December 2021DG Regio talk contribs 12,927 bytes +377 Changed label, description and/or aliases in fr: translated_label

29 October 2020

21 October 2020

  • curprev 07:2707:27, 21 October 2020DG Regio talk contribs 12,989 bytes +292 Changed label, description and/or aliases in 1 language: translated_label
  • curprev 07:2707:27, 21 October 2020DG Regio talk contribs 12,697 bytes −369 Changed label, description and/or aliases in 1 language: remove_english_label
  • curprev 07:2707:27, 21 October 2020DG Regio talk contribs 13,066 bytes +1,813 Created claim: summary (P836): The aim of the project is to increase the competitiveness of Bowil Biotech and improve its ability to develop products through innovation. The project concerns carrying out investments in tangible assets related to the upgrade of the production line existing in the company’s bionanocellulose plant. As a result of the investment, the company will be able to produce a biomaterial, which will be used in the production of Class III medical devices s...
  • curprev 07:2707:27, 21 October 2020DG Regio talk contribs 11,253 bytes −1,375 Removed claim: summary (P836): The project aims to increase the competitiveness of Bowl Biotech and improve its capacity to develop products through innovation. The project relates to the carrying out of investments in tangible assets linked to the production of a production line existing at the factory bionanoceululose of the company. As a result of the investment, the firm will be able to produce bio-material that will be used for the manufacture of class III medical devi...

24 September 2020

22 June 2020

10 June 2020

7 June 2020

26 March 2020

10 March 2020

  • curprev 10:1010:10, 10 March 2020DG Regio talk contribs 11,344 bytes +1,375 Created claim: summary (P836): The project aims to increase the competitiveness of Bowl Biotech and improve its capacity to develop products through innovation. The project relates to the carrying out of investments in tangible assets linked to the production of a production line existing at the factory bionanoceululose of the company. As a result of the investment, the firm will be able to produce bio-material that will be used for the manufacture of class III medical device...

25 February 2020

18 February 2020

31 January 2020

14 January 2020